Urgent.News

What's breaking now, across thousands of outlets.

Business

Josh Turek is running a radically centrist campaign

The Iowa Senate nominee, if he wins, could start reconstituting a red-state Democratic bloc that’s lost ground.

Josh Turek is running a radically centrist campaign

Democratic Senate candidate Josh Turek is running a campaign that positions him as a centrist in a fiercely competitive race in Iowa. Turek, a Paralympic gold medalist, is touting his bipartisan record and criticizing his party for obstructing farm and data center legislation. He recently ran ads emphasizing his votes with Republicans while distancing himself from the far-left.

Turek's campaign has gained the support of Iowans who are skeptical of the party's liberal direction. However, his opponent, Republican Ashley Hinson, accuses Turek of "masquerading" as a moderate and argues that he would likely vote with Democrats in Congress. The close race could determine control of the Senate, making Turek's moderate stance a significant factor in the election.

Written by urgent.news from Semafor's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at semafor.com →

More in Business

Innovent displays Phase I trial results for bispecific ADC IBI3001

Biopharmaceutical manufacturer Innovent Biologics showcased Phase I trial results at ESMO 2026 for IBI3001 a bispecific antibody drug conjugate targeting solid tumours

  • Innovent Biologics presents Phase 1 trial results for bispecific ADC IBI3001 at ESMO Congress.
  • 57 patients from China, Australia, and US participated in multinational study.
  • IBI3001 showed favorable safety and 30.2% overall objective response rate in advanced solid tumors.

More from Monday 26 October →